Generic Name
Dexmethylphenidate
Brand Names
Azstarys, Focalin
FDA approval date: November 30, 2001
Classification: Central Nervous System Stimulant
Form: Tablet, Capsule
What is Azstarys (Dexmethylphenidate)?
AZSTARYS is indicated for the treatment of Attention Deficit Hyperactivity Disorder in patients 6 years of age and older. AZSTARYS is a central nervous system stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder in patients 6 years of age and older.
Approved To Treat
Top Global Experts
Save this treatment for later
Not sure about your diagnosis?
Related Clinical Trials
Comparative Effectiveness of Pharmacologic Management of ADHD in Children and Youth With Autism Spectrum Disorder
Summary: This study is a pragmatic clinical trial examining the comparative effectiveness of two stimulant medications (methylphenidate and amphetamine) in the treatment of ADHD in children and adolescents with autism. Using a sequential, multiple assignment randomization trial (SMART) design the study will not only assess these two medications but also the role of an increasingly popular class of ADHD med...